Voriconazole dry powder inhalation (TFF Pharmaceuticals)

伏立康唑干粉吸入剂 (TFF Pharmaceuticals)

Report date: 2025/06/10 16:54:34

Base Information

Drug NameVoriconazole dry powder inhalation (TFF Pharmaceuticals)
Drug Alias NameInhaled voriconazoleVoriconazole Inhalation PowderVIPTFF VORI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsAsthmaInvasive Pulmonary Aspergillosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTff Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesTff Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAsthmaInvasive Pulmonary Aspergillosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A